Allchem Lifescience IPO

Allchem Lifescience IPO Details

Allchem Lifescience IPO is a 100% book-built issue, comprising a fresh issue of ₹190 crore and an offer for sale (OFS) of 71.55 lakh equity shares, with a face value of ₹10 per share. The company filed its DRHP with SEBI on March 13, 2025.

The price band and official dates of listing and subscription will be announced by the company later, but the shares are supposed to be listed on the BSE and the NSE platforms. The book-running lead manager of this issue is Emkay Global Financial Services Ltd. and the registrar to the issue is MUFG Intime India Private Ltd.

Allchem Lifescience IPO Date & Timeline

Allchem Lifescience Ltd. officially filed its Draft Red Herring Prospectus (DRHP) on March 13, 2025. However, the specific Allchem Lifescience IPO date and subscription timeline remain unannounced. Following regulatory approval, the company will finalize the price band and bidding dates. Once cleared, the schedule for anchor allotment, public bidding and the final listing on the exchange will be formally disclosed.

Allchem Lifescience IPO GMP (Grey Market Premium)

“Grey Market Premium” or GMP is defined as the rate at which the IPO's shares are traded in the market before they are officially listed on the stock exchange.

The Allchem Lifescience IPO GMP is currently trading at ₹[.], reflecting the sentiment of unofficial investors before the official listing. This premium suggests a potential listing price of ₹[.], which is [.]% above the issue price. While the Grey Market Premium is a key indicator of demand and investor appetite, it is important to remember that GMP is highly volatile and should not be the sole factor in your investment decisions.

Company Background

Allchem Lifescience Ltd. was incorporated in 2017, in Vadodara, Gujarat, with a focus on manufacturing speciality chemicals and pharmaceutical intermediates. Over the years, the company has transitioned from a developing manufacturer to an established player in the chlorination chemistry space.

The company operates in a region known as a major hub for India's chemical and pharmaceutical industries, providing logistical and infrastructural advantages. Since its inception, Allchem has focused on building a portfolio catering to high-growth industries like healthcare and agriculture, marked by a shift towards more complex chemical processes and an expanding client base.

Operations & Product Range

Allchem Lifescience Ltd. is involved in the manufacturing of intricate chemical compounds, such as speciality chemicals and intermediates required in the development of Active Pharmaceutical Ingredients (APIs), as well as those required for the creation of agrochemicals. Its proficiency in chlorination technology has enabled it to develop different types of chlorinated products that are used in the production of pharmaceuticals, as well as pesticides and herbicides in agrochemicals.

Facilities & Capacity

The manufacturing plant of Allchem Lifescience Ltd. is a state-of-the-art one based in Village Lamdapura, Manjusar, Vadodara, Gujarat. This plant is fitted with advanced reactors that can carry out high-pressure chemical reactions. The company is strategically located, the plant is near the sources of raw materials and big ports, which helps with easy transportation both within the country and abroad.

Brands & Market Presence

Allchem Lifescience Ltd. is mainly involved in the business of manufacturing goods for industry and institutions, where its presence in the market is based on its technical image and quality of products. The company has made a place for itself as a dependable vendor in the industrial corridor of Gujarat. Its exposure to exports protects it from any volatility in its home market and confirms that it adheres to global manufacturing norms.

Revenue Streams & Business Model

The primary revenue stream of Allchem Lifescience Ltd. is the sale of specialty chemicals and intermediates. The business model is centred on "Chemistry with Excellence," focusing on mastering specific chemical processes to offer high-value products to industrial buyers. In FY24, total revenue was ₹138.06 crore, with significant contributions from the pharmaceutical intermediate segment, followed by specialty chemicals and agrochemicals, as well as the export income of ₹54.53 crore, further showcasing the company's global competitiveness.

Management & Shareholding

The promoters of Allchem Lifescience Ltd. are Bipin Patel, Kantilal Ramanlal Patel, Aditi Patel and Manisha Bipin Patel. Before the IPO, the promoters collectively held the 99.98% of the pre-IPO shareholding, with the 0.02% held by the promoter group. But after the IPO, the promoter shareholding will be diluted through the fresh issue and OFS.

Board & Key Management

The leadership of Allchem Lifescience Ltd. is led by a team of experts with many years of experience. Bipin Patel serves as the Chairman & Managing Director and gives strategic direction to the firm and the daily operations, along with Whole-Time Directors Kantilal Ramanlal Patel and Aditi Patel. To ensure good governance, the board includes Independent Directors Lavina Bharatkumar Chuggani, Hemang Mehta and Rajnikanth Chimanlal Diwan for honest oversight. Together, this team uses its knowledge to help the company grow and stay successful.